Dermata Therapeutics Inc (DRMA)
1.137
-0.01
(-1.12%)
USD |
NASDAQ |
Nov 22, 16:00
1.10
-0.04
(-3.26%)
After-Hours: 20:00
Dermata Therapeutics Stock Buybacks (Quarterly): -4.545M for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -4.545M |
| June 30, 2024 | -2.409M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | -1.954M |
| September 30, 2023 | 0.0354M |
| June 30, 2023 | -1.512M |
| March 31, 2023 | -4.175M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2022 | -4.276M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.0006M |
| September 30, 2021 | -15.39M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-15.39M
Minimum
Sep 2021
0.0354M
Maximum
Sep 2023
-2.139M
Average
--
Median
Sep 2020
Stock Buybacks (Quarterly) Benchmarks
| NeuroBo Pharmaceuticals Inc | 0.00 |
| Cognition Therapeutics Inc | -0.497M |
| ZyVersa Therapeutics Inc | 0.00 |
| Bone Biologics Corp | 0.0002M |
| NovaBay Pharmaceuticals Inc | -2.858M |